Leadership
Taghogho Agarin, MD, MPH, MBA
Chief Executive Officer, co-Founder
Dr. Agarin is a double board-certified physician in Psychiatry and Pain Medicine. He finished residency training and fellowship at Harlem Hospital, affiliated with Columbia and the University of California San Diego, respectively. In the last decade, he had seen most of his patients do so well when certain combinations of medications were being used. Those combinations have been achieving great success in patient treatment. Recently working with Dr. Van Horn, they co-managed patients with a specific type of dementia and were surprised to see significant improvement in patients' neurocognitive functioning, reversing long-held views that most dementias always lead to progressive deterioration. Together, they founded Zyvran Pharmaceutical Inc. to share these successes with the rest of the world on a global platform by creating combinations that worked well in improving patients' health outcomes.
Dr. Agarin earned his medical degree from the University of Calabar, Nigeria, an MPH from Boston University, and an MBA from Fitchburg State University.
William A Van Horn, MD
Co-Founder
Dr. Van Horn is a Diplomat of the American Board of Neurology and Psychiatry with more than 25 years of experience in providing proper and effective medical treatment for all stages of Alzheimer's Dementia with results that have been unheard of in the medical or scientific community. Real-world experience from running at least two Geriatric units brimming with hundreds to thousands of dementia patients over the last two decades has helped him learn what works and what doesn't. As a result, Dr. Van Horn co-founded Zyvran Pharmaceutical Inc. with Dr. Agarin to share these results with the rest of the scientific community and hopefully engender a discussion on where further research direction should be.
Dr. Van Horn earned his medical degree from the University of South Alabama. In addition, he received specialty training at West Virginia University. Dr. Van Horn also completed his Fellowship in Geriatric Neuropsychiatry at Emory University, one of the premier institutions in treating Alzheimer's Disease.
Robert Neil McLay, MD, PhD
Vice President, Research & Development
Dr. Robert Neil McLay is a triple board-Certified physician in Psychiatry, Psychosomatic, and Pain Medicine. He was the former Research Director for Mental Health at Naval Medical Center San Diego. He brought all that knowledge and expertise to lead Zyvran’s research team in producing life-changing medicines. As one of the few MD and Ph.D. psychiatrists in the military, he was in charge of programs to advance new technologies to help Service Members deal with the stress of deployment. While deployed in Iraq in 2008, Dr. McLay tested out Virtual Reality treatments for Post-Traumatic Stress Disorder. He interviewed physicians, captains, commanders, and Service Members in the field, trying to learn what allowed one person to thrive and another to break in combat. Dr. McLay is the author of over 50 scientific articles about mental health and neuroscience and several books.
Richard Chou, MD, MBA, CPE
Advisor, Business Development
Dr Richard Chou is a board-certified practicing anesthesiologist. He is a former Navy and NASA contingency flight surgeon and covered over nine space shuttle launch and recovery missions, while back up the remaining from 2006-2011, when the shuttle program was active. He was the youngest flight surgeon flight lead covering both Cape Canerval and Edward's Air Force Base. Dr Chou also served on multiple aircraft carriers and flew over 500 hours in military aircraft, over 300 hours in fighter jets as a back seater. After his military service, he completed his anesthesiology residency at the University of California, San Francisco, focusing on regional anesthesia and trauma. In full-time private practice, he is an expert in regional anesthesia, where he serves as a member-at-large for the Practice Management and Advocacy/Guidelines Commitees as well as the Delegate to the American Medical Association for the American Society of Regional Anesthesia. Following his residency, while working full-time as an anesthesiologist, he served as the director of maritime critical care at Carnival Cruise Line and Chief Medical Officer of Carnival Asia. He has also served as a medical director of anesthesia for a major medical group. He attended the University of Pennsylvania Wharton School of Business, specializing in Finance and Entrepreneurship. He has been involved in multiple Healthcare startups. He is the co-founder, president and CEO of Quantum Analytics, which leverages technology and Artificial Intelligence to decrease the administrative workload for physicians. As a physician, he is focused on treating acute pain via peripheral nerve blocks for surgery while minimizing the use of perioperative narcotics.
Michael Callis, PhD, MSCP
Associate, Research & Development
Dr. Callis brings 25 years of experience working as a forensic psychologist in federal and state prisons and holds a Psychology License in California and New York. In addition, Dr. Callis completed an APA-accredited internship at Federal Detention Center in 1995-1996.
Dr. Callis holds a BA in History from the University of California, Los Angeles, a MA from Cal State Northridge, a Ph.D. in Psychology from the University of Southern California, and a post-doctoral master’s degree in Clinical Psychopharmacology from Alliance University.